By the comparison of KLK7 expression in four data sets, meta-analysis demonstrated that KLK7 was significantly increased in two types of ovarian cancer, namely, ovarian serous adenocarcinoma and ovarian endometrioid adenocarcinoma (Figure 2e). This evidence concerns the gene KLK7 and ovarian endometrioid adenocarcinoma.